Fig 1: Femtosecond laser induced differentiation of ADSCs into osteoblasts(A) The immunofluorescence microscopy images of Runx2 in ADSCs after laser activation on Day 3 (n=22 fields in 7 independent trials), Day 7 (n=41 fields in 14 independent trials), and Day 21 (n=25 fields in 8 independent trials). Right panel: the quantified Runx2 level.(B) The positive ratio of area staining with Alizarin Red S in the differentiated cells on Day 21 induced by dexamethasone (DEX, 10 nM), Laser (1030-nm laser at mode M (0.2 s) respectively (Control, n=41 fields in 11 independent trials; DEX, n=14 fields of view in 5 independent trials; Laser-1030 nm/0.2 s, n=31 fields in 9 independent trials). Graphs include all data points and mean ± SEM. The significance is calculated using unpaired student’s t-test (indicated with stars). ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001. Scale bar, 20 μm. This figure was reused from Tang et al. (2022).
Supplier Page from Abcam for Alexa Fluor® 488 Anti-RUNX2 antibody [EPR14334]